Cellular origin and lineage specificity of the JAK2V617F allele in polycythemia vera

被引：9

作者：

Butcher, Carolyn M. ^{[1
]}

Hutton, Jonathon F. ^{[1
]}

Hahn, Uwe ^{[1
]}

To, L. Bik ^{[1
]}

Bardy, Peter ^{[1
]}

Lewis, Ian ^{[1
]}

D'Andrea, Richard J. ^{[1
]}

机构：

[1] Child Hlth Res Inst, Adelaide, SA 5006, Australia

来源：

BLOOD | 2007年 / 109卷 / 01期

关键词：

D O I：

10.1182/blood-2006-07-036426

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：386 / 387

页数：2

共 10 条

[1] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].

Baxter, EJ ;

Scott, LM ;

Campbell, PJ ;

East, C ;

Fourouclas, N ;

Swanton, S ;

Vassiliou, GS ;

Bench, AJ ;

Boyd, EM ;

Curtin, N ;

Scott, MA ;

Erber, WN ;

Green, AR .

LANCET, 2005, 365 (9464) :1054-1061

[2] Identification of a human B-cell/myeloid common progenitor by the absence of CXCR4 [J].

Hou, YH ;

Srour, EF ;

Ramsey, H ;

Dahl, R ;

Broxmeyer, HE ;

Hromas, R .

BLOOD, 2005, 105 (09) :3488-3492

[3] Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia vera [J].

Ishii, Takefumi ;

Bruno, Edward ;

Hoffman, Ronald ;

Xu, Mingiiang .

BLOOD, 2006, 108 (09) :3128-3134

[4] Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion [J].

Iwasaki-Arai, J ;

Iwasaki, H ;

Miyamoto, T ;

Watanabe, S ;

Akashi, K .

JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (10) :1311-1322

[5] A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J].

James, C ;

Ugo, V ;

Le Couédic, JP ;

Staerk, J ;

Delhommeau, F ;

Lacout, C ;

Garçon, L ;

Raslova, H ;

Berger, R ;

Bennaceur-Griscelli, A ;

Villeval, JL ;

Constantinescu, SN ;

Casadevall, N ;

Vainchenker, W .

NATURE, 2005, 434 (7037) :1144-1148

[6] The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation [J].

Jamieson, CHM ;

Gotlib, J ;

Durocher, JA ;

Chao, MP ;

Mariappan, MR ;

Lay, M ;

Jones, C ;

Zehnder, JL ;

Lilleberg, SL ;

Weissman, IL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (16) :6224-6229

[7] Redefinition of lymphoid progenitors [J].

Katsura, Y .

NATURE REVIEWS IMMUNOLOGY, 2002, 2 (02) :127-132

[8] Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines [J].

Kondo, M ;

Scherer, DC ;

Miyamoto, T ;

King, AG ;

Akashi, K ;

Sugamura, K ;

Weissman, IL .

NATURE, 2000, 407 (6802) :383-386

[9] Mutation studies in CD3+, CD19+ and CD34+ cell fractions in myeloproliferative disorders with homozygous JAK2V617F in granulocytes [J].

Lasho, TL ;

Mesa, R ;

Gilliland, DG ;

Tefferi, A .

BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (05) :797-799

[10] Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis [J].

Levine, RL ;

Wadleigh, M ;

Cools, J ;

Ebert, BL ;

Wernig, G ;

Huntly, BJP ;

Boggon, TJ ;

Wlodarska, L ;

Clark, JJ ;

Moore, S ;

Adelsperger, J ;

Koo, S ;

Lee, JC ;

Gabriel, S ;

Mercher, T ;

D'Andrea, A ;

Fröhling, S ;

Döhner, K ;

Marynen, P ;

Vandenberghe, P ;

Mesa, RA ;

Tefferi, A ;

Griffin, JD ;

Eck, MJ ;

Sellers, WR ;

Meyerson, M ;

Golub, TR ;

Lee, SJ ;

Gilliland, DG .

CANCER CELL, 2005, 7 (04) :387-397

← 1 →